ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
Done
Inviting an author to review:
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
Find an author and click ‘
Invite to review selected article
’ near their name.
Search for authors
Search for similar articles
Invite by email
4
views
0
references
Top references
cited by
5
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,115
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
P3.02b-001 phase 1 dose escalation of PF-06747775 (EGFR-T790M inhibitor) in patients with advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC. Topic: EGFR biomarkers
Author(s):
H Husain
,
R MARTINS
,
S Goldberg
,
P Senico
,
W MA
,
J Masters
,
N Pathan
,
D.-W. Kim
,
M Socinski
,
Z. Goldberg
,
Hatim Husain
,
Renato Martins
,
Sarah Goldberg
,
Peggy Senico
,
Wendy Ma
,
Joanna Masters
,
Nuzhat Pathan
,
Dong-Wan Kim
,
Mark A. Socinski
,
Zelanna I Goldberg
,
Byoung Cho
,
R Martins
,
W. Ma
Publication date:
2017
Journal:
Journal of Thoracic Oncology
Read this article at
ScienceOpen
Publisher
Further versions
open (via crossref license)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Coronaviruses, COVID-19 and SARS-CoV-2
Author and article information
Journal
DOI::
10.1016/j.jtho.2016.11.1668
ScienceOpen disciplines:
Infectious disease & Microbiology
Data availability:
ScienceOpen disciplines:
Infectious disease & Microbiology
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,115
In Silico Study of Secondary Metabolites from Brucea javanica as EGFR Mutant T790M-L858R- V948R Inhibitor
Authors:
Mohammad Pratama
Determinación de mutaciones (del E746-A750 exón 19 y L858R exón 21) en el gen receptor del factor de crecimiento epidérmico (EGFR) en muestras de suero y biopsia de carcinoma pulmonar no microcítico (CPNM)
Authors:
Karla Castro-Valencia
,
Lizbeth González-Herrera
,
Elena Muñoz-Santos
…
Transtinib, a potent tyrosine kinase inhibitor inhibits L858R/T790M mutant NSCLC cell lines and xenografts
Authors:
Peng Hu
,
Da-xiong Han
,
Run-Sheng Ruan
…
See all similar
Cited by
5
Strategies to overcome acquired resistance to EGFR TKI in the treatment of non-small cell lung cancer
Authors:
J. Gao
,
H-R Li
,
C. Jin
…
Challenge and countermeasures for EGFR targeted therapy in non-small cell lung cancer.
Authors:
Xueli Tian
,
Tingxuan Gu
,
Mee-Hyun Lee
…
Third-Generation Tyrosine Kinase Inhibitors Targeting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
Authors:
Tristan A. Barnes
,
Grainne O’Kane
,
Mark David Vincent
…
See all cited by